SHC - Sotera Health Company Real Price to Acquire Entire Company

Brandmark of Nordion (SHC)

The primary threats to Sotera Health Company (SHC) involve potential regulatory claims regarding product processing quality, as well as environmental disputes. The business relies on stable demand for laboratory testing and sterilization, ensuring medical safety. This price chart, where the Enterprise Value is 7247.87, confirms the company's status as a global leader with colossal barriers to entry due to the high cost of radiation chambers.

SHC Sotera Health Company Enterprise Value (11/23/2025 - 10/30/2026)
Flagship merchandise of Sotera Health Company

Enterprise Value represents the total value of a business, combining market capitalization and net debt to determine the actual cost of a full asset buyout. By analyzing the Enterprise Value level on this chart, an investor can assess the fairness of the price relative to the stable cash flows from the critical sterilization services of Sotera Health Company (SHC), which provide the company with resilience against market volatility.

Who Sotera Health Company competes with

Value Adjusted for Debt and Cash A|Quest - Enterprise Value|Illumina Platform (ILMN) - Real Price to Acquire Entire Company|Exact Sciences (EXAS) - Total Company Value|Real Price to Acquire Entire Company revvity.com|BIO (Bio-Rad) - Enterprise Value|Total Enterprise Value Anbio Biotechnology Ltd NNNN|Enterprise Value QDEL|OPKO Health Corp. - Business Value|Enterprise Value CDNA (CareDx Corp)|Enterprise Value maravai.com MRVI|FLGT - Total Company Value|LAB (Standard BioTools Inc) - Business Value|CTKB: Enterprise Value|OraSure Corp (OSUR) - Enterprise Value|Total Company Value Exagen Inc|Total Company Value MDXH|Real Price to Acquire Entire Company LUCD (Lucid Diagnostics)|PRE - Total Enterprise Value|Total Company Value Insight Molecular Diagnostics Inc IMDX|Company Buyout Price Trinity Biotech PLC (TRIB)|ProPhase Labs, Inc. - Enterprise Value|Company Buyout Price ainos.com AIMD|Co-Diagnostics (CODX) - Total Company Value|HSCS - Company Buyout Price|Total Company Value Biomerica, Inc|Cardio Diagnostics Holdings, Inc. (CDIO) - Company Buyout Price|Total Company Value Virax Biolabs Group (VRAX)|BJDX - Total Enterprise Value|Aspira Women's Health Inc. - Real Price to Acquire Entire Company|Aggregate Business Value AXDX (Accelerate Diagnostics Inc.)|Centogene - Enterprise Value|Total Enterprise Value Enzo Biochem, Inc.|fresh2.co (FRES) - Total Company Value|Genetic Technologies Limited - Value Adjusted for Debt and Cash|ME (23andMe) - Enterprise Value|Enterprise Value Psychemedics Corp.